Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Barr Challenges Two 3M Process Patents On Raw Materials For Tambocor

Executive Summary

Barr's manufacturing of flecainide does not infringe on two 3M process patents covering the raw materials for Tambocor, Barr maintained in its patent challenge for the anti-arrythmia agent.

You may also be interested in...

Barr Generic Tambocor Launch Planned For Fall Following Win In Patent Case

Barr is planning to launch a generic version of 3M's Tambocor (flecainide) in the fall following a favorable court decision in a patent infringement case.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts